Cargando…

Editorial: Vascular co-option and beyond for cancer biology

Detalles Bibliográficos
Autores principales:	Pezzella, Francesco, Qian, Chao-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338838/ https://www.ncbi.nlm.nih.gov/pubmed/37456261 http://dx.doi.org/10.3389/fonc.2023.1227540

Ejemplares similares

Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma
por: Ribatti, Domenico, et al.
Publicado: (2022)

Vascular co‐option and vasculogenic mimicry mediate resistance to antiangiogenic strategies
por: Pezzella, Francesco, et al.
Publicado: (2020)

Editorial: Cancer stem cell differentiation: A realistic potential therapeutic option?
por: Buccarelli, Mariachiara, et al.
Publicado: (2023)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Editorial: Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond
por: Khan, Abdul Arif, et al.
Publicado: (2023)

Editorial: Metastasis: From Cell Adhesion and Beyond
por: Gkretsi, Vasiliki, et al.
Publicado: (2019)

Editorial: Cancer Care Delivery and Women’s Health: Beyond the Patient and Provider Relationship
por: Temkin, Sarah M.
Publicado: (2017)

Editorial: Single cell meets metabolism and cancer biology
por: Wang, Jieqiong, et al.
Publicado: (2023)

Editorial: Evidence and emerging option in diagnosis and management of upper tract urothelial carcinomas
por: Liu, Liangren, et al.
Publicado: (2022)

Tumor vessel co-option: The past & the future
por: Cuypers, Anne, et al.
Publicado: (2022)

Editorial: The Biological Landscape of Immunotherapy in AML
por: Isidori, Alessandro, et al.
Publicado: (2021)

Tumor vasculature: a sally port for inhibiting cancer cell spreading
por: Qian, Chao-Nan, et al.
Publicado: (2018)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Editorial: Stomatal Biology and Beyond
por: Ye, Wenxiu, et al.
Publicado: (2022)

Editorial: Biology and treatment of high-risk CLL
por: Tausch, Eugen, et al.
Publicado: (2023)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

Editorial: Biological aspects of bone marrow failure
por: Diamantopoulos, Panagiotis, et al.
Publicado: (2023)

Editorial: Reviews in gastrointestinal cancers
por: Manu, Kanjoormana Aryan, et al.
Publicado: (2023)

Editorial: Advances in Biological Understanding of Tumor Radiation Resistance
por: Skvortsova, Ira Ida, et al.
Publicado: (2020)

Editorial: Systems biology and single-cell analysis of cancer metabolism and its role in cancer emergent properties
por: Jia, Dongya, et al.
Publicado: (2023)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

Editorial: Molecular biology of biomarkers in diagnosis and treatment of glioblastoma multiforme
por: Zhao, Jianyi, et al.
Publicado: (2023)

Editorial: Understanding leukemia biology using genome editing techniques
por: Jimenez-Morales, Silvia, et al.
Publicado: (2023)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Editorial: Emerging engineering approaches in cancer immunotherapy
por: Xu, Jialu, et al.
Publicado: (2022)

Editorial: Lymph node assessment in cervical cancer
por: Guani, Benedetta, et al.
Publicado: (2023)

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)

Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression
por: Horani, Malek, et al.
Publicado: (2023)

Editorial: Biomarkers and immunotherapy of hepatic-biliary-pancreatic cancers
por: Qian, Yawei, et al.
Publicado: (2023)

Editorial: Emerging strategies for cancer therapy targeting ferroptosis
por: Li, Manshan, et al.
Publicado: (2023)

Coumarins and Gastrointestinal Cancer: A New Therapeutic Option?
por: Banikazemi, Zarrin, et al.
Publicado: (2021)

Molecular Network of Colorectal Cancer and Current Therapeutic Options
por: Huang, Zhe, et al.
Publicado: (2022)

Editorial: Application of radiomics in understanding tumor biological behaviors and treatment response
por: Xiao, Ningping, et al.
Publicado: (2023)

Editorial: Targeting DNA repair and the DNA damage response: Beyond the standard PI3 kinase-like kinases
por: Turchi, John J., et al.
Publicado: (2022)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Editorial: Cellular stress in blood cancer: Pathophysiology and therapeutic opportunities
por: Costoya, José A., et al.
Publicado: (2022)

Editorial: Extracellular vesicle-derived non-coding RNAs (EV-ncRNAs) and their multifaceted roles in cancer biology
por: Neamati, Nahid, et al.
Publicado: (2023)

The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer
por: Zhang, Chunye, et al.
Publicado: (2020)

Application of systemic treatment in conversion therapy options for liver cancer
por: Bei, Haoyang, et al.
Publicado: (2022)

Editorial: Cancer Models
por: Breitenbach, Michael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_il3r4bes7nj1vf7m77nticonr9